Computational Docking Analysis of Protein-Ligand Interactions in Diabetes-Related Complications: Targeting Molecular Pathways for Therapeutic Intervention

Authors

  • Soumya G Research Scholar, Department of Computer Science, University of Technology, Jaipur, Rajasthan
  • Dr. Suhas Rajaram Mache Professor, Department of Computer Science, University of Technology, Jaipur, Rajasthan

DOI:

https://doi.org/10.29070/1xcpbp06

Keywords:

Diabetes-Related, ZINC database, data bank, drug design, anti-diabetic

Abstract

A key tenet of the scientific method is the integration of computational resources into the chemical and biological domains to facilitate the discovery and development of new pharmaceuticals. A major public health concern in India is diabetes. An immediate start is required to begin the research and development of a novel diabetic therapy. Type 2 diabetes remains incurable despite the availability of several therapies. Target identification, interactions between proteins and ligands, and residues in the active site form the basis of drug design. Our focus here is on five conserved and very active amino acid residues from five proteins with essential roles in diabetes. A variety of docking methods were used to investigate the binding mechanism and affinities of drug-like compounds, chalcones, some plant chemicals, and other potential anti-diabetic medications from the virtual screening database (ZINC) (free database). The protein data bank was searched for the three-dimensional structural coordinates of 1AH3 (Aldose Reductase) according to the results in literature and the Root Mean Square Deviation (RMSD).

References

Sooriyakala Rani Sri Prakash (2023) Type 2 diabetes mellitus. Nat Rev Dis Primers 2015;1:15019.

Vishal Chavda (2023) Tools and Approaches for the Prediction of Functional and Structural Effects of Single-Nucleotide Polymorphisms on Proteins: An Expert Review. Omi. A J. Integr. Biol.2021, 25, 23– 37,https://doi.org/10.1089/omi.2020.0141.

Almasi, Faezeh &Mohammadipanah, Fatemeh. (2020). Prominent and emerging anti-diabetic molecular targets. Journal of Drug Targeting. 29. 1-16. 10.1080/1061186X.2020.1859517.

Walters, W.P.; Stahl, M.T.; Murcko, M.A. Virtual screening - an overview. Drug Discov. Today, 2018, 3, 160-178

Langer, T.; Hoffmann, R.D. Virtual screening: an effective tool for lead structure discovery? Curr. Pharm. Des., 2001, 7, 509-527.

Furr, J.R.; Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov., 2023, 3, 935-949.

Gohlke, H.; Klebe, G. Approaches to the description and prediction of the binding affinity of smallmolecule ligands to macromolecular receptors. Angew. Chem. Int. Ed. Engl., 2022, 41, 2644-2676.

D.; Lawandi, J.; Corbeil, C.R. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. Br. J. Pharmacol., 2018, 153(Suppl 1), S7-26.

Irwin, J.J. In: Hits, leads and artifacts from virtual and high throughput screening., Molecular Informatics: Confronting Complexity, 2020.

Bailey, D.; Brown, D. High-throughput chemistry and structure based design: survival of the smartest. Drug Discov. Today, 2024, 6, 57-59.

S.J.; Langridge, R.; Ferrin, T.E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol., 2023, 161, 269-288.

Sobolev, V.; Edelman, M. The performance of current methods in ligand-protein docking. Curr. Sci., 2022, 83, 845-855.

Downloads

Published

2024-10-01

How to Cite

[1]
“Computational Docking Analysis of Protein-Ligand Interactions in Diabetes-Related Complications: Targeting Molecular Pathways for Therapeutic Intervention”, JASRAE, vol. 21, no. 7, pp. 245–254, Oct. 2024, doi: 10.29070/1xcpbp06.

How to Cite

[1]
“Computational Docking Analysis of Protein-Ligand Interactions in Diabetes-Related Complications: Targeting Molecular Pathways for Therapeutic Intervention”, JASRAE, vol. 21, no. 7, pp. 245–254, Oct. 2024, doi: 10.29070/1xcpbp06.